These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 23508379)
1. A brief review of Japanese guidelines for the clinical use of (18)F-FDG-PET/MRI 2012 (Ver 1.0). Kaneta T Ann Nucl Med; 2013 May; 27(4):309-13. PubMed ID: 23508379 [TBL] [Abstract][Full Text] [Related]
2. Standardization of quantitative imaging: the time is right, and 18F-FDG PET/CT is a good place to start. Buckler AJ; Boellaard R J Nucl Med; 2011 Feb; 52(2):171-2. PubMed ID: 21233179 [No Abstract] [Full Text] [Related]
3. Operational radiation safety for PET-CT, SPECT-CT, and cyclotron facilities. Zanzonico P; Dauer L; St Germain J Health Phys; 2008 Nov; 95(5):554-70. PubMed ID: 18849690 [TBL] [Abstract][Full Text] [Related]
4. American College of Radiology and Society of Nuclear Medicine and Molecular Imaging Joint Credentialing Statement for PET/MR Imaging: Brain. Jadvar H; Subramaniam RM; Berman CG; Boada F; Colletti PM; Guimaraes AR; McConathy J; Meltzer CC; Noto RB; Packard AB; Rohren EM; Oates ME J Nucl Med; 2015 Apr; 56(4):642-5. PubMed ID: 25745088 [No Abstract] [Full Text] [Related]
5. Concurrent PET/CT with an integrated imaging system: intersociety dialogue from the Joint Working Group of the American College of Radiology, the Society of Nuclear Medicine, and the Society of Computed Body Tomography and Magnetic Resonance. Coleman RE; Delbeke D; Guiberteau MJ; Conti PS; Royal HD; Weinreb JC; Siegel BA; Federle MP; Townsend DW; Berland LL; ; ; J Am Coll Radiol; 2005 Jul; 2(7):568-84. PubMed ID: 17411882 [TBL] [Abstract][Full Text] [Related]
6. The Medical Imaging & Technology Alliance conference on research endpoints appropriate for medicare coverage of new PET radiopharmaceuticals. Hillman BJ; Frank RA; Abraham BC J Am Coll Radiol; 2013 Sep; 10(9):689-94. PubMed ID: 23916799 [TBL] [Abstract][Full Text] [Related]
7. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer. Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736 [TBL] [Abstract][Full Text] [Related]
8. Preoperative staging of liver metastases from uveal melanoma by magnetic resonance imaging (MRI) and fluorodeoxyglucose-positron emission tomography (FDG-PET). Servois V; Mariani P; Malhaire C; Petras S; Piperno-Neumann S; Plancher C; Levy-Gabriel C; Lumbroso-le Rouic L; Desjardins L; Salmon RJ Eur J Surg Oncol; 2010 Feb; 36(2):189-94. PubMed ID: 19775851 [TBL] [Abstract][Full Text] [Related]
12. The radioprotection management of a PET department with a cyclotron and radiopharmacy laboratory, in accordance with Italian legislation. Russo AA; Ferrari P; Casale M; Delia R Radiat Prot Dosimetry; 2011 Sep; 147(1-2):240-6. PubMed ID: 22039292 [TBL] [Abstract][Full Text] [Related]
13. 18F-FDG PET/CT, 99mTc-MIBI, and MRI in evaluation of patients with multiple myeloma. Fonti R; Salvatore B; Quarantelli M; Sirignano C; Segreto S; Petruzziello F; Catalano L; Liuzzi R; Rotoli B; Del Vecchio S; Pace L; Salvatore M J Nucl Med; 2008 Feb; 49(2):195-200. PubMed ID: 18199607 [TBL] [Abstract][Full Text] [Related]
14. Standardized uptake values for [¹⁸F] FDG in normal organ tissues: comparison of whole-body PET/CT and PET/MRI. Heusch P; Buchbender C; Beiderwellen K; Nensa F; Hartung-Knemeyer V; Lauenstein TC; Bockisch A; Forsting M; Antoch G; Heusner TA Eur J Radiol; 2013 May; 82(5):870-6. PubMed ID: 23394765 [TBL] [Abstract][Full Text] [Related]
15. The efficacy of brain (18)F-fluorodeoxyglucose positron emission tomography in neuropsychiatric lupus patients with normal brain magnetic resonance imaging findings. Lee SW; Park MC; Lee SK; Park YB Lupus; 2012 Dec; 21(14):1531-7. PubMed ID: 22941565 [TBL] [Abstract][Full Text] [Related]
16. [Recommendations for the use of PET-CT with 18F-FDG in radiotherapy planning]. García Vicente AM Rev Esp Med Nucl Imagen Mol; 2012; 31(6):364. PubMed ID: 23063325 [No Abstract] [Full Text] [Related]
17. F-18 FDG PET evaluation of bronchial plasmacytoma with CT and MRI correlation. Iagaru A; Mari C; Segall G Clin Nucl Med; 2006 May; 31(5):279-80. PubMed ID: 16622337 [No Abstract] [Full Text] [Related]
18. A meta-analysis of ¹⁸FDG-PET-CT, ¹⁸FDG-PET, MRI and bone scintigraphy for diagnosis of bone metastases in patients with lung cancer. Qu X; Huang X; Yan W; Wu L; Dai K Eur J Radiol; 2012 May; 81(5):1007-15. PubMed ID: 21354739 [TBL] [Abstract][Full Text] [Related]
19. Clinical role of 18F-FDG PET/CT in the management of squamous cell carcinoma of the head and neck and thyroid carcinoma. Quon A; Fischbein NJ; McDougall IR; Le QT; Loo BW; Pinto H; Kaplan MJ J Nucl Med; 2007 Jan; 48 Suppl 1():58S-67S. PubMed ID: 17204721 [TBL] [Abstract][Full Text] [Related]
20. Inter-modality comparisons of seizure focus lateralization in complex partial seizures. Meyer PT; Cortés-Blanco A; Pourdehnad M; Levy-Reis I; Desiderio L; Jang S; Alavi A Eur J Nucl Med; 2001 Oct; 28(10):1529-40. PubMed ID: 11685497 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]